Associated Banc Corp Buys 2,425 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Associated Banc Corp increased its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 5.7% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 44,976 shares of the financial services provider’s stock after buying an additional 2,425 shares during the quarter. Associated Banc Corp owned about 0.09% of iShares Biotechnology ETF worth $6,549,000 at the end of the most recent reporting period.

Other hedge funds have also recently added to or reduced their stakes in the company. O Shaughnessy Asset Management LLC raised its stake in iShares Biotechnology ETF by 19.5% in the first quarter. O Shaughnessy Asset Management LLC now owns 1,986 shares of the financial services provider’s stock valued at $273,000 after purchasing an additional 324 shares in the last quarter. Waverly Advisors LLC raised its position in shares of iShares Biotechnology ETF by 80.6% in the 1st quarter. Waverly Advisors LLC now owns 11,220 shares of the financial services provider’s stock valued at $1,540,000 after buying an additional 5,006 shares in the last quarter. Jane Street Group LLC bought a new stake in shares of iShares Biotechnology ETF during the 1st quarter worth approximately $14,386,000. Comerica Bank lifted its holdings in shares of iShares Biotechnology ETF by 6.7% during the 1st quarter. Comerica Bank now owns 18,629 shares of the financial services provider’s stock worth $2,556,000 after acquiring an additional 1,169 shares during the period. Finally, Pacific Center for Financial Services lifted its holdings in shares of iShares Biotechnology ETF by 21.1% during the 1st quarter. Pacific Center for Financial Services now owns 620 shares of the financial services provider’s stock worth $85,000 after acquiring an additional 108 shares during the period. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

NASDAQ:IBB traded up $2.10 during mid-day trading on Monday, reaching $140.06. The stock had a trading volume of 305,487 shares, compared to its average volume of 1,444,607. The stock has a 50-day simple moving average of $143.43 and a two-hundred day simple moving average of $141.87. iShares Biotechnology ETF has a 12 month low of $117.28 and a 12 month high of $150.57.

iShares Biotechnology ETF Dividend Announcement

The firm also recently announced a dividend, which was paid on Monday, September 30th. Shareholders of record on Wednesday, September 25th were issued a $0.2005 dividend. The ex-dividend date of this dividend was Wednesday, September 25th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.